Ruiz-Villaverde, RArmario-Hita, J CDominguez-Cruz, JPereyra-Rodriguez, Jose Juan2023-02-092023-02-092020-06-09http://hdl.handle.net/10668/15728enAttribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/Antibodies, Monoclonal, HumanizedDermatitis, AtopicHospitalsHumansReferral and ConsultationThe Safety of Dupilumab in Clinical Practice: 52 Weeks of Experience at 5 Referral Hospitals in Andalusia.Análisis de seguridad de dupilumab en práctica clínica real. Experiencia a 52 semanas de cinco centros de referencia en Andalucía.research article32531242open access10.1016/j.ad.2019.05.0072173-5778https://doi.org/10.1016/j.ad.2019.05.007